Cellicon Valley '23: The Future of Cell and Gene Therapies

When: Wednesday, June 21 – Friday, June 23, 2023

Where: In Person at Irvine Auditorium (3401/3417 Spruce Street Philadelphia, PA 19104) or Virtually via AJI Media Livecast powered by Accelevents

When: Wednesday, June 21 – Friday, June 23, 2023

Where: In Person at Irvine Auditorium (3401/3417 Spruce Street Philadelphia, PA 19104) or Virtually via AJI Media Livecast powered by Accelevents

Learning Objectives:

Upon completion of this symposium, participants should be able to:

• Identify current application of CAR T-cell therapy including: disease indication, accurate patient selection, manufacturing and treatment administration for adult and pediatric patients
• Describe the latest for CAR T-Cell Therapy for T Cell ALL, multiple myeloma and CLL
• List challenges and opportunities for equitable patient access
• Explain the risk of malignancies and curative therapies for hemoglobinopathies
• Identify the current status of globalization of cell and gene therapies
• Describe the latest targets and technologies for CARs
• Define toxicity and its management
• Identify mechanisms of resistance and how to overcome it
• List recent advances in cell therapy for solid tumors
• Describe chimeric antigen receptor T Cells for T Cell malignancies
• Identify the latest evidence based standards in nursing care resulting from the recent advances in cell therapy and transplant:
  • Identify advances in re-treatment
  • List the latest updates in fertility preservation
  • Describe the challenges with navigating and coordination of BMT/cell gene therapies and CAR-T
  • Explain how bispecific antibodies work
  • List standards of care and practice related to cell therapy infusion day
  • Repeat the rationale for nursing to remain current with new and upcoming therapies